Ignite Creation Date:
2024-05-06 @ 9:00 AM
Last Modification Date:
2024-10-26 @ 12:08 PM
Study NCT ID:
NCT02876081
Status:
WITHDRAWN
Last Update Posted:
2017-09-11
First Post:
2016-08-18
Brief Title:
Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma Harboring Wild-type EGFR Expressing the Neurotensin - Neurotensin Receptor Complex
Sponsor:
Fondation Hôpital Saint-Joseph
Organization:
Fondation Hôpital Saint-Joseph
Organization Data
Organization:
Fondation Hôpital Saint-Joseph
Class:
OTHER
Study ID:
Afatinib THEN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None